Fatigue associated with multiple sclerosis: diagnosis, impact and management.

作者: Rohit Bakshi

DOI: 10.1191/1352458503MS904OA

关键词:

摘要: In patients with multiple sclerosis (MS) fatigue is the most common symptom and one of disabling features. As many as 40% have described it single symptom--a higher percentage than weakness, spasticity, motor problems, or bowel bladder problems. The etiology pathophysiology MS-related remain unknown. Studies failed to demonstrate an association between level disability, clinical disease subtype, gender, although recent data show depression quality life. Imaging studies using positron emission tomography suggest that in MS related hypometabolism specific brain areas, including frontal subcortical circuits. impact on patient functioning life clearly warrants intervention. addition nonpharmacologic measures, such exercise energy conservation strategies, several pharmacologic agents been evaluated for their ability reduce fatigue, amantadine, central nervous system stimulants (pemoline), novel wake-promoting agent modafinil.

参考文章(43)
Vallabh Janardhan, Rohit Bakshi, Quality of life in patients with multiple sclerosis: the impact of fatigue and depression. Journal of the Neurological Sciences. ,vol. 205, pp. 51- 58 ,(2002) , 10.1016/S0022-510X(02)00312-X
Freal Je, Kraft Gh, Coryell Jk, Symptomatic fatigue in multiple sclerosis Archives of Physical Medicine and Rehabilitation. ,vol. 65, pp. 135- 138 ,(1984)
T.J. Murray, Amantadine therapy for fatigue in multiple sclerosis. Canadian Journal of Neurological Sciences. ,vol. 12, pp. 251- 254 ,(1985) , 10.1017/S0317167100047107
John D. Fisk, Amanda Pontefract, Paul G. Ritvo, Catherine J. Archibald, T.J. Murray, The Impact of Fatigue on Patients with Multiple Sclerosis Canadian Journal of Neurological Sciences. ,vol. 21, pp. 9- 14 ,(1994) , 10.1017/S0317167100048691
Thomas E. Scammell, Ivy V. Estabrooke, Marie T. McCarthy, Richard M. Chemelli, Masashi Yanagisawa, Matthew S. Miller, Clifford B. Saper, Hypothalamic Arousal Regions Are Activated during Modafinil-Induced Wakefulness The Journal of Neuroscience. ,vol. 20, pp. 8620- 8628 ,(2000) , 10.1523/JNEUROSCI.20-22-08620.2000
Margot Schubert, Kai Wohlfarth, Jens D. Rollnik, Reinhard Dengler, Walking and fatigue in multiple sclerosis: the role of the corticospinal system. Muscle & Nerve. ,vol. 21, pp. 1068- 1070 ,(1998) , 10.1002/(SICI)1097-4598(199808)21:8<1068::AID-MUS12>3.0.CO;2-Q
R. Djaldetti, I. Ziv, A. Achiron, E. Melamed, Fatigue in multiple sclerosis compared with chronic fatigue syndrome A quantitative assessment Neurology. ,vol. 46, pp. 632- 635 ,(1996) , 10.1212/WNL.46.3.632
L. B. Krupp, L. E. Elkins, Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology. ,vol. 55, pp. 934- 939 ,(2000) , 10.1212/WNL.55.7.934
J.-S. Lin, Y. Hou, M. Jouvet, Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 14128- 14133 ,(1996) , 10.1073/PNAS.93.24.14128
Jane A. Kent-Braun, Khema R. Sharma, Michael W. Weiner, Robert G. Miller, Effects of exercise on muscle activation and metabolism in multiple sclerosis Muscle & Nerve. ,vol. 17, pp. 1162- 1169 ,(1994) , 10.1002/MUS.880171006